Skip to main content
Clinical Trials/IRCT20130523013442N31
IRCT20130523013442N31
Recruiting
Phase 3

Comparison of ultrasound-guided corticosteroid and botulinum toxin in frozen shoulder

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Shahid Beheshti University of Medical Sciences
Enrollment
60
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • People aged 30 to 60 years
  • Diagnosed with adhesive capsulitis based on history and physical examination
  • No response to conservative treatments, including non\-steroidal anti\-inflammatory drugs, opioids, exercise therapy, and physical therapy.
  • A score of 5 or higher based on the intensity of the pain (according to the VAS criteria)
  • Less than 6 months have passed since the onset of the symptoms
  • Have more than 30 degree reduction in the range of motion in at least 2 of the 4 directions of motion (abduction, flexion, external rotation, and internal rotation) compared to the range of motion of the healthy shoulder (opposite side)

Exclusion Criteria

  • History of shoulder trauma in the last 6 months
  • History of humerus fracture
  • Pregnancy and breastfeeding
  • The presence of nerve damage or neurological disorders that cause dysfunction of the upper limbs, including brachial plexopathy, hemiplegia, and peripheral nerve damage.
  • Allergy or known sensitivity to botulinum toxin or corticosteroids
  • Presence of psychological problems
  • History of shoulder surgery
  • A patient who is unable to cooperate to check the range of motion due to severe pain
  • History of intra\-articular injection in the last 6 months
  • Inflammatory systemic diseases

Outcomes

Primary Outcomes

Not specified

Similar Trials